"Precancerous Conditions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions that tend eventually to become malignant.
Descriptor ID |
D011230
|
MeSH Number(s) |
C04.834
|
Concept/Terms |
Precancerous Conditions- Precancerous Conditions
- Condition, Precancerous
- Conditions, Precancerous
- Precancerous Condition
Condition, Preneoplastic- Condition, Preneoplastic
- Preneoplastic Condition
- Preneoplastic Conditions
- Conditions, Preneoplastic
|
Below are MeSH descriptors whose meaning is more general than "Precancerous Conditions".
Below are MeSH descriptors whose meaning is more specific than "Precancerous Conditions".
This graph shows the total number of publications written about "Precancerous Conditions" by people in this website by year, and whether "Precancerous Conditions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 5 | 3 | 8 |
1995 | 9 | 4 | 13 |
1996 | 5 | 2 | 7 |
1997 | 7 | 4 | 11 |
1998 | 9 | 2 | 11 |
1999 | 10 | 6 | 16 |
2000 | 10 | 8 | 18 |
2001 | 10 | 5 | 15 |
2002 | 9 | 3 | 12 |
2003 | 15 | 6 | 21 |
2004 | 9 | 9 | 18 |
2005 | 15 | 10 | 25 |
2006 | 24 | 9 | 33 |
2007 | 14 | 11 | 25 |
2008 | 27 | 9 | 36 |
2009 | 23 | 7 | 30 |
2010 | 17 | 15 | 32 |
2011 | 24 | 6 | 30 |
2012 | 20 | 5 | 25 |
2013 | 13 | 6 | 19 |
2014 | 15 | 3 | 18 |
2015 | 13 | 5 | 18 |
2016 | 8 | 6 | 14 |
2017 | 12 | 5 | 17 |
2018 | 17 | 5 | 22 |
2019 | 15 | 2 | 17 |
2020 | 6 | 4 | 10 |
2021 | 6 | 2 | 8 |
2022 | 13 | 0 | 13 |
2023 | 13 | 0 | 13 |
To return to the timeline,
click here.
Below are the most recent publications written about "Precancerous Conditions" by people in Profiles.
-
Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management. Ann Surg Oncol. 2024 Apr; 31(4):2224-2230.
-
A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions. Cancer Med. 2023 11; 12(21):20626-20638.
-
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma. Mod Pathol. 2023 Dec; 36(12):100326.
-
TIME for Bugs: The Immune Microenvironment and Microbes in Precancer. Cancer Prev Res (Phila). 2023 09 01; 16(9):497-505.
-
Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention. Cancer Prev Res (Phila). 2023 09 01; 16(9):483-495.
-
Transcription factor expression repertoire basis for epigenetic and transcriptional subtypes of colorectal cancers. Proc Natl Acad Sci U S A. 2023 08; 120(31):e2301536120.
-
Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. Cancer Cell. 2023 08 14; 41(8):1407-1426.e9.
-
From Premalignant Biology to Precision Interception: Connecting the Dots with a Curated Collection of Invited Articles. Cancer Prev Res (Phila). 2023 07 05; 16(7):365-367.
-
A Comprehensive Program to Improve Treatment of Precancerous Cervical Lesions in the Rio Grande Valley of Texas. J Public Health Manag Pract. 2024 Jan-Feb 01; 30(1):89-98.
-
Validation of a pre-endoscopy risk score for predicting the presence of gastric intestinal metaplasia in a U.S. population. Gastrointest Endosc. 2023 10; 98(4):569-576.e1.